XenoGesis will be attending this year’s Bio Integrates conference on the 22nd May in London, with CEO Richard Weaver joining the panel.
Richard is part of the advisory board which aims to provide expert insight into the critical issues and challenges facing the bio industry.
Bio Integrates was inspired by the ongoing success of the established Pharma Integrates event. This one-day event will attract start-ups, SMEs and emerging companies providing a platform to discuss the major challenges impacting the pharma and biotech sector.
Addressing topics such as precision medicine, cell and gene therapy, artificial intelligence, in silico and virtual trials, the focus will be on collaboration, involving stakeholders such as patient advocates, clinicians, CDMOs and CROs, charities, manufacturers, academics and medtechs.
Comprising roundtable discussions, breakout sessions and keynote presentations, delegates will benefit from updates on industry wide initiatives, alternative business models, innovative deal structures, partnering with CROs, CDMOs and the wider supply chain.
The event takes place on 22 May 2019 at the Grange Tower Bridge Hotel in London and is hosted in collaboration with BioNow and One Nucleus. For more information and details on how to register, click here.